| 23 Jun 2025 | 10:30:28 | Withdrawl of 'Stmt re Share Price Movement' RNS |
| 23 Jun 2025 | 10:05:53 | Statement re Share Price Movement |
| 23 Jun 2025 | 07:00:11 | Resignation of Nominated Adviser |
| 27 Feb 2025 | 07:00:04 | Interim Results |
| 7 Feb 2025 | 16:22:45 | TR-1: Notification of major holdings |
Craven House Capital PLC is an investment company that focuses on acquiring or investing in a range of assets, including businesses and joint ventures. Its investment portfolio includes shareholdings in two quoted early-stage pharmaceutical companies listed in Stockholm and minority shareholdings in five private businesses operating in the eCommerce and pharmaceutical sectors. The company primarily serves the pharmaceutical and eCommerce markets and operates in the United Kingdom and Sweden.
| 23 Jun 2025 | 10:30:28 | Withdrawl of 'Stmt re Share Price Movement' RNS |
| 23 Jun 2025 | 10:05:53 | Statement re Share Price Movement |
| 23 Jun 2025 | 07:00:11 | Resignation of Nominated Adviser |
| 27 Feb 2025 | 07:00:04 | Interim Results |
| 7 Feb 2025 | 16:22:45 | TR-1: Notification of major holdings |
Craven House Capital PLC is an investment company that focuses on acquiring or investing in a range of assets, including businesses and joint ventures. Its investment portfolio includes shareholdings in two quoted early-stage pharmaceutical companies listed in Stockholm and minority shareholdings in five private businesses operating in the eCommerce and pharmaceutical sectors. The company primarily serves the pharmaceutical and eCommerce markets and operates in the United Kingdom and Sweden.
